中文 | English
Return
Total: 4613 , 1/462
Show Home Prev Next End page: GO
Author:(Feng HUANG)

1.Interleukin-2 and its receptor abnormalities in Ankylosing Spondylitis and Rheumatoid Arthritis

Feng HUANG

Chinese Journal of Immunology 1985;0(03):-

2.Influential factors of human immunodeficiency virus infection in adolescents

Feng-rong, HUANG ; Hong, HUANG

Journal of Shanghai Jiaotong University(Medical Science) 2009;29(7):798-801

3.The Analysis on compared between before and post application of coding on classification of disease clinical modification of Beijing

Feng HUANG ; Jianpeng ZHENG

Chinese Journal of Hospital Administration 2011;27(11):860-862

4.Present situation and suggestion on training the research ability of post-graduate students of basic medicine

Jiayi HUANG ; Tao FENG

Chinese Journal of Medical Education Research 2011;10(4):486-488

5.Clinical and laboratory features of scleroderma patients with pulmonary hypertension and risk factors for the incidence

Wei ZHAO ; Feng HUANG

Chinese Journal of Rheumatology 2003;0(08):-

6.Study of correlation of diabetic nephropathy with serum endothelin(ET-1) and C-reactive protein(CRP)

Wen HUANG ; Weihua FENG

Chinese Journal of Diabetes 2009;17(11):842-843

7.Segmental splenectomy, the first choice for treatment of splenic benign tumor

Bo HUANG ; Bianxi FENG

Chinese Journal of Hepatobiliary Surgery 2010;16(6):410-412

8.Clinical characters of juvenile onset spondyloarthropathies

Jianglin ZHANG ; Feng HUANG

Chinese Journal of Rheumatology 2001;5(2):113-116

9.Detection and significance of urokinase-type plasminogen activator and its receptor in synovial fluid and plasma in rheumatoid arthritis

Chunhua YANG ; Feng HUANG

Chinese Journal of Rheumatology 2001;5(3):148-151

10.Development of a computer-aided cephalometric analysis system based on screen input

Sen YAO ; Feng HUANG

Journal of Practical Stomatology 2001;17(2):89-92

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4613 , 1/462 Show Home Prev Next End page: GO